Visionaire Health Economics Study Comparing Economic Outcomes Between Visionaire and Standard Instrumentation

Osteoarthritis, Knee Clinical Trial

— VISHE13  

Official title:

A Prospective, Randomised Pilot Study to Compare Health Economic Outcomes Using a Patient-matched Cutting Guide Versus Standard Instrumentation in Total Knee Arthroplasty.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02158819
• Other study ID #: VISHE.13
• Status: Completed
• Phase: N/A
• Start date: July 9, 2014
• Est. completion date: May 15, 2017

Study information

• Verified date: January 2019
• Source: Smith & Nephew, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose and primary objective of this study is to compare health economic outcomes between the use of a patient-matched cutting guide (Visionaire) versus the use of standard instrumentation in Total Knee Arthroplasty(TKA). Data will be collected pre-operatively, intra-operatively and post operatively up until and including the six week post-operative assessment. The secondary objectives of the study are to compare safety and early readmission rates between the two techniques. The study hypothesis is that there is no difference in the cost of the episode of care from hospital admission to discharge, including pre-operative radiology costs and cost of resources, with the Visonaire patient-matched cutting guide compared to standard instrumentation.

Description:

This is a prospective, randomised pilot study comparing the health economic outcomes between TKA using standard instrumentation and TKA using a patient-matched cutting guide. The primary indication for this study is degenerative arthritis of the knee requiring unilateral primary total knee arthroplasty. Patients requiring TKA who are eligible and have consented to participate will be randomised to TKA with The Genesis II™ Total Knee Implant System or the Legion™ Primary Total Knee System using either Visionaire™ patient-matched cutting guides or standard instrumentation. The study will recruit for 1 year and patients will have a final follow up at the six week post-operative assessment.

The primary objective of this study will evaluate the cost of the episode of care from hospital admission to discharge. This will include pre-operative costs, anesthetic costs, operative and theatre costs, costs of instruments and resources. The study will also measure length of stay as well as blood transfusion requirements. The secondary objectives of this study are to compare the safety and early readmission rates between the two techniques, by measuring the complication rates intra-operatively and post-operatively as well as the number of patients readmitted to hospital prior to the six week post-operative assessment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 52
• Est. completion date: May 15, 2017
• Est. primary completion date: May 15, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Degenerative arthritis of the knee requiring unilateral primary Total Knee Arthroplasty in subjects for whom the use of patient-matched cutting guides or standard instrumentation are, in the surgeon's opinion, clinically appropriate and acceptable forms of treatment;

• Patient is of legal age to consent and is skeletally mature;

• The patient is able to fully understand the purpose of the trial, and his/her role as a participant in the study

• The patient consents to his/her inclusion in the study after the nature, scope and possible consequences of the study have been explained in an understandable form.

Exclusion Criteria:

• Patient is known to have poor bone stock making a Total Knee Arthroplasty unjustifiable.

• Patient is immuno-suppressed.

• Patient has physical, emotional or neurological conditions that would compromise the subject's compliance with postoperative rehabilitation and follow-up.

• Patient is pregnant or may become pregnant during the course of the study, or is lactating.

• Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as Anterior Cruciate Ligament repair, meniscectomy, or arthroscopy are not excluded.

• Patient has active, localized or systemic infection.

• Patient is severely overweight (BMI >40).

• Patient is a prisoner.

• Patient has a significant MRI (magnetic resonance imaging) exclusion or contraindication.

• Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.

• Patient presently identified with future need for bilateral TKA within the next twenty-four months.

• Patient has a known or suspected hypersensitivity/allergy to foreign materials contained in the implant

Related Conditions & MeSH terms

• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Device:
• Total knee arthroplasty with Visionaire
Patient Specific Instrumentation

Locations

Country	Name	City	State
South Africa	Life Claremont Hospital	Cape Town	Western Cape
South Africa	Private Practice	Durban	Kwazulu Natal
South Africa	Sunninghill Hospital	Johannesburg	Gauteng
South Africa	Life Bay View Hospital	Mossel Bay	Cape Town
South Africa	Pretoria East Hospital	Pretoria	Gauteng

Sponsors (1)

Lead Sponsor	Collaborator
Smith & Nephew, Inc.

Country where clinical trial is conducted

South Africa, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cost of the episode of care from admission to hospital to discharge	The cost of the episode of care from admission to hospital to discharge , including pre-operative radiology costs and costs associated with Visionaire and will incorporate the costs of time, number of instruments utilised, blood transfusion requirements, length of stay and pre-operative xray and MRI costs.	up to 1 week
Secondary	Percentage of patients that experience short term complications and/or early readmissions	Percentage of patients experiencing intra-operative complications, post operative complications, post discharge complications or readmissions prior to the 6 week post-operative assessment.	up to 6 weeks